Imaging Mass Spectrometrist to perform single-cell metabolomics
Are you an expert in all things related to mass spectrometry? Do you enjoy working in a start-up environment with cutting-edge research?
We are looking for an Imaging Mass Spectrometrist to join the SpaceM Bio Studio Project at the BioInnovation Institute (BII).
Incubated by the Novo Nordisk Foundation, BII’s mission is to create new life science solutions to address unmet societal or health needs. At BII, we have established a new program, Bio Studio, which aims to build life science start-ups based on world-class research. Bio Studio projects are three year grant funded projects, sourced from leading researchers employed at research institutions worldwide. The projects we admit combine scientific novelty, commercial viability, and the potential for significant societal and/or health impact. The goal of the projects is to create a viable start-up company based on the project within three years.
BII aims to recruit a strong project team for each Bio Studio project, and it is expected that this team will form the core of the future start-up deriving from the project. Apart from establishing a solid Project Team, BII provides a comprehensive network of industry, investors, and subject matter experts to support the projects.
Your Opportunity to Join BII’s Bio Studio Program!
The SpaceM project aims to develop and commercialize a recently invented technology for single-cell metabolomics for drug discovery and precision medicine. The project PI is Dr. Theodore Alexandrov from European Molecular Biology Laboratory (Heidelberg) who is a world leader in single-cell metabolomics and was previously co-founder of a startup developing software in a related field. Dr. Alexandrov’s team at EMBL has developed the foundational technology that generates big data representing levels of drugs or metabolites inside single cells. This information can be of high value for both fundamental understanding of cellular responses and as a tool for drug development. The SpaceM project will further develop and streamline the technology, algorithms and software to be applied to address key questions in drug discovery and precision medicine.
You will join a dynamic team of talented and experienced scientists and engineers excited to make translational impact through development of novel technologies. We offer a start-up culture focused on efficiency and collaborative work with minimal hierarchy and bureaucracy yet with professional approach to project management. Moreover, integration of the project team in the BioInnovation Institute Bio Studio provides attractive and competitive work conditions, multiple learning opportunities, and involvement in a vibrant entrepreneurial network.
Your ownership of our mutual journey will be to:
- Operating and maintaining a cutting-edge MALDI imaging mass spectrometry system
- Developing and optimizating imaging mass spectrometry methods
- Setting up and executing QC approaches
- Performing MALDI-imaging analyses
- Together with other experimentalists and computational scientists, planning experiments as well as streamlining samples preparation, data acquisition, and data analysis
- Performing data analysis together with data scientists
You will report directly to the CIO of BII, Trine Bartholdy. This role is based on a 3-year contract, with the possibility of an extension.
Your Professional & Personal Spirit
We are looking for a team member who has an MSc or PhD in analytical chemistry or another related field, and experience and in-depth knowledge of mass spectrometry and untargeted metabolomics.
Further to this, you have:
- Experience in method development for mass spectrometry
- Hands-on experience in mass spectrometry troubleshooting and tuning knowledge of principles of data analysis
- Experience in MALDI imaging mass spectrometry is preferable
- Experience in data analysis and/or close collaboration with data scientists is a plus
- Knowledge of cell biology and microscopy is a plus
As a person, you are structured and curious, with an interest for working in a start-up environment. You enjoy working in a small team, whilst being in constant interaction with outside stakeholders as well. Importantly, you are motivated by translating research into commercially viable projects.
Your Experience Working at BII
We offer a committed and professional workplace in which we emphasize ensuring that our colleagues thrive, are challenged, and have opportunities to develop their potential. A career at BII allows you to work with world-leading entrepreneurial scientists in a position where you will have a substantial chance to impact your job and the opportunity to develop your bio entrepreneurial skills.
BII invites you to become part of a vibrant and professional workplace with a chance to bring ideas to life and science to market for the benefit of society and human welfare.
Application and Information
For more information, please contact Markus Herrgård, Chief Technical Officer via e-mail: firstname.lastname@example.org or on the phone: +45 24921780. The deadline for applying for this job is 06/07/2022. However, we will hold interviews on a rolling basis, and therefore encourage you to send your application as soon as possible.
To apply, please submit your CV and cover letter by clicking on the “Apply now” button via this link https://novo.csod.com/ux/ats/careersite/5/home/requisition/360?c=novo.
About the BioInnovation Institute Foundation
The BioInnovation Institute foundation (BII) is an international commercial foundation with a nonprofit objective supported by the Novo Nordisk Foundation. BII operates an incubator to accelerate world-class life science innovation that drives the development of new solutions by early life science start-ups for the benefit of people and society.
BII, located in Copenhagen, Denmark, offers start-ups and early-stage projects within health tech, therapeutics and bioindustrials state-of-the-art labs, vibrant office facilities, business development, start-up business incubation, access to high-level mentoring and international networks, plus unique funding opportunities of up to 1.3 million euro per start-up and 2.4 million euro per project.
Since the inauguration of BII in November 2018, BII has awarded 35 million euros to 68 high-growth start-up companies. Read more on www.bioinnovationinstitute.com